Burden of disease

Burden of disease analysis assesses the health impact on a population of different diseases, conditions, injuries and risk factors. The Australian Burden of Disease Study 2015 (AIHW 2019a) used information from a range of sources to quantify the fatal and non-fatal effects of these diseases.

Type 2 diabetes was the 12th largest contributor to Australia’s disease burden in 2015, accounting for 2.2% of total burden of disease. The burden from Type 2 diabetes increased slightly in 2011 (from 1.8% in 2003) and remained unchanged between 2011 and 2015 (2.2%).  Type 1 diabetes contributed to 0.3% of Australia’s disease burden in 2015—unchanged compared to both 2003 and 2011.

In 2015, 4.7% of the total burden of disease could have been prevented by reducing exposure to the modifiable risk factor high blood plasma glucose levels.


In 2015–16, an estimated 2.3% ($2.7 billion) of total disease expenditure in the Australian health system was attributed to Diabetes (AIHW 2019b). Further information is available from the Disease expenditure in Australia report.


AIHW (Australian Institute of Health and Welfare) 2019a. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2015. Australian Burden of Disease series no. 19. Cat. no. BOD 22. Canberra: AIHW. Viewed 25 June 2019,

AIHW 2019b. Disease expenditure in Australia. HWE 76. Canberra: AIHW. Viewed 13 June 2019,